SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) Fundamental Analysis & Valuation

ELI:SLBEN • PTSLB0AM0010

Current stock price

6.6 EUR
-0.18 (-2.65%)
Last:

This SLBEN.LS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SLBEN.LS Profitability Analysis

1.1 Basic Checks

  • SLBEN had negative earnings in the past year.
  • In the past year SLBEN has reported a negative cash flow from operations.
  • In multiple years SLBEN reported negative net income over the last 5 years.
  • In the past 5 years SLBEN always reported negative operating cash flow.
SLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFSLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

  • The Return On Assets of SLBEN (6.02%) is better than 84.09% of its industry peers.
  • With an excellent Return On Equity value of 30.59%, SLBEN belongs to the best of the industry, outperforming 88.64% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 11.88%, SLBEN belongs to the best of the industry, outperforming 84.09% of the companies in the same industry.
Industry RankSector Rank
ROA 6.02%
ROE 30.59%
ROIC 11.88%
ROA(3y)0.34%
ROA(5y)-1.77%
ROE(3y)-1.66%
ROE(5y)-9.84%
ROIC(3y)N/A
ROIC(5y)N/A
SLBEN.LS Yearly ROA, ROE, ROICSLBEN.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

1.3 Margins

  • SLBEN has a better Profit Margin (18.66%) than 93.18% of its industry peers.
  • In the last couple of years the Profit Margin of SLBEN has declined.
  • SLBEN has a better Operating Margin (26.95%) than 95.45% of its industry peers.
  • SLBEN's Operating Margin has declined in the last couple of years.
  • SLBEN has a Gross Margin (53.73%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of SLBEN has grown nicely.
Industry RankSector Rank
OM 26.95%
PM (TTM) 18.66%
GM 53.73%
OM growth 3YN/A
OM growth 5Y-11.5%
PM growth 3YN/A
PM growth 5Y-12.9%
GM growth 3Y3.32%
GM growth 5Y6.61%
SLBEN.LS Yearly Profit, Operating, Gross MarginsSLBEN.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SLBEN.LS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SLBEN is creating value.
  • The number of shares outstanding for SLBEN remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, SLBEN has about the same amount of shares outstanding.
  • SLBEN has a better debt/assets ratio than last year.
SLBEN.LS Yearly Shares OutstandingSLBEN.LS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
SLBEN.LS Yearly Total Debt VS Total AssetsSLBEN.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 0.54, we must say that SLBEN is in the distress zone and has some risk of bankruptcy.
  • SLBEN has a Altman-Z score of 0.54. This is comparable to the rest of the industry: SLBEN outperforms 40.91% of its industry peers.
  • SLBEN has a Debt/Equity ratio of 1.23. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.23, SLBEN is in line with its industry, outperforming 43.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACC1.82
WACC6.51%
SLBEN.LS Yearly LT Debt VS Equity VS FCFSLBEN.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • SLBEN has a Current Ratio of 0.48. This is a bad value and indicates that SLBEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.48, SLBEN is doing worse than 86.36% of the companies in the same industry.
  • SLBEN has a Quick Ratio of 0.48. This is a bad value and indicates that SLBEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.48, SLBEN is doing worse than 86.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
SLBEN.LS Yearly Current Assets VS Current LiabilitesSLBEN.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SLBEN.LS Growth Analysis

3.1 Past

  • The earnings per share for SLBEN have decreased strongly by -844.68% in the last year.
  • The Earnings Per Share has been decreasing by -3.75% on average over the past years.
  • SLBEN shows a decrease in Revenue. In the last year, the revenue decreased by -8.56%.
  • SLBEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.50% yearly.
EPS 1Y (TTM)-844.68%
EPS 3YN/A
EPS 5Y-3.75%
EPS Q2Q%-381.43%
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y10.84%
Revenue growth 5Y10.5%
Sales Q2Q%-13.8%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLBEN.LS Yearly Revenue VS EstimatesSLBEN.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

Find the best growth stocksShow best growing peers

0

4. SLBEN.LS Valuation Analysis

4.1 Price/Earnings Ratio

  • SLBEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLBEN.LS Price Earnings VS Forward Price EarningsSLBEN.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLBEN.LS Per share dataSLBEN.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SLBEN.LS Dividend Analysis

5.1 Amount

  • No dividends for SLBEN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SLBEN.LS Fundamentals: All Metrics, Ratios and Statistics

SPORT LISBOA E BENFICA-FUT S

ELI:SLBEN (3/13/2026, 7:00:00 PM)

6.6

-0.18 (-2.65%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap151.80M
Revenue(TTM)179.04M
Net Income(TTM)35.59M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B 1.31
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.83
FCFYN/A
OCF(TTM)-2.5
OCFYN/A
SpS8.29
BVpS5.06
TBVpS-2.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 6.02%
ROE 30.59%
ROCE 15.04%
ROIC 11.88%
ROICexc 12.11%
ROICexgc 26.13%
OM 26.95%
PM (TTM) 18.66%
GM 53.73%
FCFM N/A
ROA(3y)0.34%
ROA(5y)-1.77%
ROE(3y)-1.66%
ROE(5y)-9.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y3.6%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.68%
OM growth 3YN/A
OM growth 5Y-11.5%
PM growth 3YN/A
PM growth 5Y-12.9%
GM growth 3Y3.32%
GM growth 5Y6.61%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 52.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 0.54
F-Score4
WACC6.51%
ROIC/WACC1.82
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)45.58%
Cap/Sales(5y)48.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-844.68%
EPS 3YN/A
EPS 5Y-3.75%
EPS Q2Q%-381.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y10.84%
Revenue growth 5Y10.5%
Sales Q2Q%-13.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y965.12%
EBIT growth 3YN/A
EBIT growth 5Y-2.21%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0%
OCF growth 3YN/A
OCF growth 5YN/A

SPORT LISBOA E BENFICA-FUT S / SLBEN.LS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SLBEN.LS.


Can you provide the valuation status for SPORT LISBOA E BENFICA-FUT S?

ChartMill assigns a valuation rating of 0 / 10 to SPORT LISBOA E BENFICA-FUT S (SLBEN.LS). This can be considered as Overvalued.


Can you provide the profitability details for SPORT LISBOA E BENFICA-FUT S?

SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) has a profitability rating of 5 / 10.